Drug Price Soars $0 to $375,000–NBC Ignores Role of FDA Regulation

A treatment for LEMS, Amifampridine, a.k.a., 3,4-DAP, soars in price from $0 to $375,000. NBC News (of course) ignores the role of FDA regulation of Big Pharma.

Share

9:28 pm on February 15, 2019